Correlation Between Reviva Pharmaceuticals and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Unicycive Therapeutics, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Unicycive Therapeutics.
Diversification Opportunities for Reviva Pharmaceuticals and Unicycive Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Reviva and Unicycive is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and Unicycive Therapeutics
Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to generate 1.68 times more return on investment than Unicycive Therapeutics. However, Reviva Pharmaceuticals is 1.68 times more volatile than Unicycive Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about -0.32 per unit of risk. If you would invest 186.00 in Reviva Pharmaceuticals Holdings on October 26, 2024 and sell it today you would earn a total of 5.00 from holding Reviva Pharmaceuticals Holdings or generate 2.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. Unicycive Therapeutics
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| Unicycive Therapeutics |
Reviva Pharmaceuticals and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and Unicycive Therapeutics
The main advantage of trading using opposite Reviva Pharmaceuticals and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |